However, for comparison, in the treatment of colitis, 0.005 to 0.23 mg of the substance was administered via one subcutaneous injection every 2 days for 8 days, with results comparable to the administration of 0.03 mg of an anti-TNF-α antibody. Here, TNF is linked to colitis.